HomeORKA • NASDAQ
add
Oruka Therapeutics Inc
Previous close
$28.11
Day range
$27.45 - $28.98
Year range
$5.49 - $29.46
Market cap
1.36B USD
Avg Volume
507.24K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 28.43M | 32.27% |
Net income | -24.57M | -10.48% |
Net profit margin | — | — |
Earnings per share | -0.46 | — |
EBITDA | -28.41M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 328.41M | 2,071.85% |
Total assets | 357.42M | 1,671.33% |
Total liabilities | 13.78M | -70.20% |
Total equity | 343.64M | — |
Shares outstanding | 37.45M | — |
Price to book | 3.09 | — |
Return on assets | -19.35% | — |
Return on capital | -19.97% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -24.57M | -10.48% |
Cash from operations | -23.14M | -109.78% |
Cash from investing | 4.86M | — |
Cash from financing | 109.00K | 106.86% |
Net change in cash | -18.18M | -44.00% |
Free cash flow | -13.31M | -378.05% |
About
Founded
2024
Headquarters
Website
Employees
28
